<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01228006</url>
  </required_header>
  <id_info>
    <org_study_id>NATEMS0310</org_study_id>
    <secondary_id>Version 02 - March 11, 2010</secondary_id>
    <nct_id>NCT01228006</nct_id>
  </id_info>
  <brief_title>Study for Effectiveness Evaluation of Panax Ginseng, Vitamins and Minerals (Natugerin®) in Improvement of Stress and Fatigue</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azidus Brasil</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azidus Brasil</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is hoped that the group treated with Panax Ginseng, Vitamins and Minerals obtain
      significant reduction in levels of stress and fatigue and that the results are superior to
      the placebo group.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate the efficacy of the product Natus Gerin, compared to placebo, ® in improving symptoms of stress and fatigue in patients with clinical diagnosis of mild to moderate stress</measure>
    <time_frame>14 and 28 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement in quality of sexual function.</measure>
    <time_frame>14 and 28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement in quality of life.</measure>
    <time_frame>14 and 28 days.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Decrease stress during treatment (28 days)</measure>
    <time_frame>14 and 28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Decrease fatigue during treatment (28 days)</measure>
    <time_frame>14 and 28 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Stress</condition>
  <condition>Fatigue</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>NatusGerin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Gelatin capsules identical to drug test</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>NatusGerin</intervention_name>
    <description>1 capsule, 2 times a day.</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo capsules</intervention_name>
    <description>1 capsule, 2 times a day</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Agree with all study procedures, signing the IC in two ways, by his own free will;

          -  Patients older than 18 years, male or female, regardless of ethnicity or social class;

          -  Presence of pictures of mild to moderate stress, confirmed with the aid of the Stress
             Symptom Inventory (ISS), which considers stress and mild to moderate classification
             Alert classification Resistance;

          -  Presence frame of fatigue with a score greater than 36 according to the Fatigue
             Severity Scale (FSS).

        Exclusion Criteria:

          -  Participation in clinical trials in the 12 months preceding the survey;

          -  Current treatment with drugs that are stimulants or central nervous system depressants
             such as hypnotics, anxiolytics, antipsychotics, antidepressants, statins and muscle
             relaxants;

          -  Alternative Therapies that scientifically, or have no influence in the tables of
             stress or fatigue as acupuncture or relaxing massages;

          -  Treatment psychotherapeutic medication or not;

          -  Current treatment or prediction of treatment with oral anticoagulants (due to
             interaction with the tocopherol);

          -  Women who are pregnant or lactating;

          -  Patients with lactose intolerance;

          -  Patients allergic to soy or peanuts;

          -  chronic renal failure;

          -  Patients using other multivitamins or individual vitamins such as vitamin D and / or
             A.

          -  Chronic alcoholism;

          -  Patients with clinical diagnosis of diseases causing severe chronic pain or adversely
             affect the clinical interpretation as fibromyalgia, multiple sclerosis, neuropathies
             and myopathies;

          -  Patients with hypothyroidism or hyperthyreosis diagnosed clinically;

          -  Patient history and physical examination suggestive of severe hepatorenal failure;

          -  Patients with decompensated diabetes mellitus (fasting glucose above 180 mg / dL);

          -  Patients being treated for cancer;

          -  Amendment of the routine of life during the study as early vacation or suspected
             change in working hours;

          -  Patients with complaints of excessive sleepiness caused by organic source frameworks
             such as sleep apnea and morbid obesity (BMI above 35);

          -  History of hypersensitivity to any component of the product under investigation;

          -  Any finding of clinical observation (clinical history or physical examination) that is
             interpreted by the physician investigator as a risk to the patient's participation in
             the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alexandre Frederico, Physician</last_name>
    <phone>55 19 38293822</phone>
    <email>alexandre@lalclinica.com.br</email>
  </overall_contact>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 8, 2010</study_first_submitted>
  <study_first_submitted_qc>October 22, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 25, 2010</study_first_posted>
  <last_update_submitted>October 22, 2010</last_update_submitted>
  <last_update_submitted_qc>October 22, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 25, 2010</last_update_posted>
  <responsible_party>
    <name_title>Alexandre Frederico</name_title>
    <organization>LAL Clinica Pesquisa e Desenvolvimento Ltda</organization>
  </responsible_party>
  <keyword>Reduction of stress and fatigue</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatigue</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

